ACET Q2 2021 Earnings — Adicet Bio, Inc. Revenue & Financial Results | Market Cap Arena

ACETAdicet Bio, Inc.

$71M

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5M-35.5% YoY

Gross Profit

$5M100.0% margin

Operating Income

-$11M-224.9% margin

Net Income

-$11M-225.5% margin

EPS (Diluted)

$-5.44

QoQ Revenue Growth

+220.9%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$15M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$269M

Total Liabilities

$40M

Stockholders' Equity

$228M

Cash & Equivalents

$209M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$7M	-35.5%
Gross Profit	$5M	$7M	-35.5%
Operating Income	-$11M	-$9M	-25.5%
Net Income	-$11M	-$8M	-28.4%